Swiss biotech ecosystem recuperates from global financial instability [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
Swiss biotech revenues reached CHF 7.3bn ($8.06bn), as per an report by the same association. However, whilst the Swiss private biotech ecosystem is flourishing, experts say there is space for growth in the country's public markets. As the country where pharma giants like Novartis and Roche first started, Switzerland has long been a stronghold for pharmaceutical companies. However, the country was not unaffected by the stiff biotech ecosystem that affected the rest of the world in 2023. Geopolitical tensions from conflicts such as the Ukraine-Russia war, and the residual effects of the Covid-19 pandemic kept interest rates high in 2023, making several dealmakers more risk averse. The Organization for Economic Cooperation and Development (OECD) reports that Switzerland has a projected global gross domestic product (GDP) growth of 3.2% by 2025, coinciding with a 3.4% rise in inflation in the same period. In recent times, several Swiss companies wound down their operations, began
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (NASDAQ:CRSP) shareholders have endured a 59% loss from investing in the stock three years ago [Yahoo! Finance]Yahoo! Finance
- 3 Dirt Cheap Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy? [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 8/5/24 - Miss
CRSP
Sec Filings
- 8/12/24 - Form 4
- 8/5/24 - Form S-3ASR
- 8/5/24 - Form S-8
- CRSP's page on the SEC website